Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Human african trypanosomiasis (HAT) / sleeping sickness
CH-FDJP-CHE110141200-13
EUR 63.94mdeclared budget
EUR 55.30mdisbursed and spent, 2,638 of 2,638 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2003 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 58.47m → EUR 63.94m (+9.4%)
- Transactions added: 357 transactions added, EUR 8.40m
Human african trypanosomiasis (HAT) / sleeping sickness · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 8.75m | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 6.99m | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 7.50m | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 8.27m | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 8.57m | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 9.50m | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 8.88m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 5.47m | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 8.75m | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 6.99m | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 7.50m | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 8.27m | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 8.57m | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 9.50m | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 8.88m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2019-05-31 | Expenditure | EUR 1,500 | CH-FDJP-CHE110141200 | Expenses - 13-1905-1-IT-DAC-1601 | |
| 2024-01-31 | Expenditure | EUR 426 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-BR-DAC-1601 | new |
| 2024-01-31 | Expenditure | EUR 1,159 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-BR | new |
| 2024-01-31 | Expenditure | EUR 6,680 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-BR | new |
| 2024-01-31 | Expenditure | EUR 2,729 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-4-BR-NO-BRC-971277882 | new |
| 2024-01-31 | Expenditure | EUR 134 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-5-BR | new |
| 2024-01-31 | Expenditure | EUR -3,665 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-CG-FR-3 | new |
| 2024-01-31 | Expenditure | EUR 4,057 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-CG-DAC-1601 | new |
| 2024-01-31 | Expenditure | EUR 58k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-CG | new |
| 2024-01-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-4-CG | new |
| 2024-01-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-5-CG-NO-BRC-971277882 | new |
| 2024-01-31 | Expenditure | EUR -1,610 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-6-CG | new |
| 2024-01-31 | Expenditure | EUR 2,440 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-CH | new |
| 2024-01-31 | Expenditure | EUR 215k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-CH-DAC-1601 | new |
| 2024-01-31 | Expenditure | EUR 58k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-CH | new |
| 2024-01-31 | Expenditure | EUR 706 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-4-CH | new |
| 2024-01-31 | Expenditure | EUR 44k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-5-CH-XM-DAC-7 | new |
| 2024-01-31 | Expenditure | EUR 88k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-6-CH-NO-BRC-971277882 | new |
| 2024-01-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-7-CH-CH-4 | new |
| 2024-01-31 | Expenditure | EUR 6,671 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-8-CH | new |
| 2024-01-31 | Expenditure | EUR 2,681 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-KE-DAC-1601 | new |
| 2024-01-31 | Expenditure | EUR 2,013 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-KE | new |
| 2024-01-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-KE-NO-BRC-971277882 | new |
| 2024-01-31 | Expenditure | EUR 2,640 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-4-KE | new |
| 2024-01-31 | Expenditure | EUR 346 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-MY | new |
| 2024-01-31 | Expenditure | EUR 822 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-MY | new |
| 2024-01-31 | Expenditure | EUR 1,054 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-MY-NO-BRC-971277882 | new |
| 2024-01-31 | Expenditure | EUR 6,354 | Drugs for Neglected Diseases initiative | Expenses - 13-2401-1-US | new |
| 2024-01-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-2-US-XM-DAC-7 | new |
| 2024-01-31 | Expenditure | EUR -11k | Drugs for Neglected Diseases initiative | Expenses - 13-2401-3-US | new |
| 2024-02-29 | Expenditure | EUR 1,571 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-BR-DAC-1601 | new |
| 2024-02-29 | Expenditure | EUR 729 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-BR | new |
| 2024-02-29 | Expenditure | EUR 4,517 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-3-BR | new |
| 2024-02-29 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-4-BR-XM-DAC-7 | new |
| 2024-02-29 | Expenditure | EUR 1,704 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-5-BR-NO-BRC-971277882 | new |
| 2024-02-29 | Expenditure | EUR 297 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-6-BR | new |
| 2024-02-29 | Expenditure | EUR 275 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-CG | new |
| 2024-02-29 | Expenditure | EUR 1,241 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-CG-DAC-1601 | new |
| 2024-02-29 | Expenditure | EUR 51k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-3-CG | new |
| 2024-02-29 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-4-CG | new |
| 2024-02-29 | Expenditure | EUR 246 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-5-CG-XM-DAC-7 | new |
| 2024-02-29 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-6-CG-NO-BRC-971277882 | new |
| 2024-02-29 | Expenditure | EUR 1,833 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-CH | new |
| 2024-02-29 | Expenditure | EUR 363k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-CH-DAC-1601 | new |
| 2024-02-29 | Expenditure | EUR 46k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-3-CH | new |
| 2024-02-29 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-4-CH | new |
| 2024-02-29 | Expenditure | EUR 5,928 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-5-CH-XM-DAC-7 | new |
| 2024-02-29 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-6-CH-NO-BRC-971277882 | new |
| 2024-02-29 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 13-2402-7-CH | new |
| 2024-02-29 | Expenditure | EUR 3,469 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-8-CH | new |
| 2024-02-29 | Expenditure | EUR 52 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-KE-DAC-1601 | new |
| 2024-02-29 | Expenditure | EUR 1,936 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-KE | new |
| 2024-02-29 | Expenditure | EUR 8,560 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-3-KE-NO-BRC-971277882 | new |
| 2024-02-29 | Expenditure | EUR 3,430 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-4-KE | new |
| 2024-02-29 | Expenditure | EUR 314 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-MY | new |
| 2019-05-31 | Expenditure | EUR 1,320 | CH-FDJP-CHE110141200 | Expenses - 13-1905-1-KE | |
| 2019-05-31 | Expenditure | EUR 1,377 | CH-FDJP-CHE110141200 | Expenses - 13-1905-1-US-DAC-1601 | |
| 2019-05-31 | Expenditure | EUR 493 | CH-FDJP-CHE110141200 | Expenses - 13-1905-2-CD | |
| 2018-01-31 | Expenditure | EUR 1,774 | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-BE-DAC-1601 | |
| 2018-01-31 | Expenditure | EUR 189k | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-CD-DAC-1601 | |
| 2018-01-31 | Expenditure | EUR 1,292 | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-CH-CH-4 | |
| 2018-01-31 | Expenditure | EUR 42k | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-CH-DAC-1601 | |
| 2018-01-31 | Expenditure | EUR 4,033 | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-CH-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 72k | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-FR-DAC-1601 | |
| 2018-01-31 | Expenditure | EUR 1,170 | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-FR-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 7,475 | CH-FDJP-CHE110141200 | Expenses - 13-1801-1-GB-DAC-1601 | |
| 2018-01-31 | Expenditure | EUR 1 | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-CD-CH-4 | |
| 2018-01-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-CD-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 35k | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-CD-XM-DAC-7 | |
| 2018-01-31 | Expenditure | EUR 25k | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-CH-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 3,847 | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-CH-XM-DAC-7 | |
| 2018-01-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-FR-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 8,395 | CH-FDJP-CHE110141200 | Expenses - 13-1801-2-GB-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 13-1801-3-CD-GB-GOV-1 | |
| 2018-01-31 | Expenditure | EUR 14k | CH-FDJP-CHE110141200 | Expenses - 13-1801-3-CH-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 3,580 | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-BE-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 177k | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-CD-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 2,488 | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-CD-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 41k | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-CH-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 88k | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-FR-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-GB-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 476 | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-GN-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 3,769 | CH-FDJP-CHE110141200 | Expenses - 13-1802-1-US-DAC-1601 | |
| 2018-02-28 | Expenditure | EUR 30k | CH-FDJP-CHE110141200 | Expenses - 13-1802-2-CD-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 44k | CH-FDJP-CHE110141200 | Expenses - 13-1802-2-CH-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 3,764 | CH-FDJP-CHE110141200 | Expenses - 13-1802-2-CH-XM-DAC-7 | |
| 2018-02-28 | Expenditure | EUR 126k | CH-FDJP-CHE110141200 | Expenses - 13-1802-2-FR-XM-DAC-7 | |
| 2018-02-28 | Expenditure | EUR 16k | CH-FDJP-CHE110141200 | Expenses - 13-1802-2-GB-GB-GOV-1 | |
| 2018-02-28 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 13-1802-3-CH-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 7,980 | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-BE-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 175k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-CD-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 52k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-CH-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 300 | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-DE-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 87k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-FR-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 2,730 | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-FR-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 229k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-GB-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-IT-XM-DAC-7 | |
| 2018-03-31 | Expenditure | EUR 7,429 | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-SN-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 15k | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-US-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 2,214 | CH-FDJP-CHE110141200 | Expenses - 13-1803-1-ZA-DAC-1601 | |
| 2018-03-31 | Expenditure | EUR 23k | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-CD-GB-GOV-1 | |
| 2024-02-29 | Expenditure | EUR 1,376 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-MY | new |
| 2024-02-29 | Expenditure | EUR 1,161 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-3-MY-NO-BRC-971277882 | new |
| 2024-02-29 | Expenditure | EUR 14 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-1-US-DAC-1601 | new |
| 2024-02-29 | Expenditure | EUR 6,288 | Drugs for Neglected Diseases initiative | Expenses - 13-2402-2-US | new |
| 2024-03-31 | Expenditure | EUR 1,415 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-BR | new |
| 2024-03-31 | Expenditure | EUR 4,531 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-BR | new |
| 2024-03-31 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-3-BR-XM-DAC-7 | new |
| 2024-03-31 | Expenditure | EUR 1,938 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-4-BR-NO-BRC-971277882 | new |
| 2024-03-31 | Expenditure | EUR 4 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-5-BR | new |
| 2024-03-31 | Expenditure | EUR 316 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-CG-DAC-1601 | new |
| 2024-03-31 | Expenditure | EUR 77k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-CG | new |
| 2024-03-31 | Expenditure | EUR 111k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-3-CG | new |
| 2024-03-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-4-CG-NO-BRC-971277882 | new |
| 2024-03-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-CH | new |
| 2024-03-31 | Expenditure | EUR 141k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-CH-DAC-1601 | new |
| 2024-03-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-3-CH | new |
| 2024-03-31 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-4-CH | new |
| 2024-03-31 | Expenditure | EUR 435 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-5-CH-XM-DAC-7 | new |
| 2024-03-31 | Expenditure | EUR 32k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-6-CH-NO-BRC-971277882 | new |
| 2024-03-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-7-CH | new |
| 2024-03-31 | Expenditure | EUR 3,429 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-8-CH | new |
| 2024-03-31 | Expenditure | EUR 856 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-KE | new |
| 2024-03-31 | Expenditure | EUR 275 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-KE-DAC-1601 | new |
| 2024-03-31 | Expenditure | EUR 3,958 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-3-KE | new |
| 2024-03-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 13-2403-4-KE-NO-BRC-971277882 | new |
| 2024-03-31 | Expenditure | EUR 6,821 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-5-KE | new |
| 2024-03-31 | Expenditure | EUR 343 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-MY | new |
| 2024-03-31 | Expenditure | EUR 1,233 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-MY | new |
| 2024-03-31 | Expenditure | EUR 828 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-3-MY-NO-BRC-971277882 | new |
| 2024-03-31 | Expenditure | EUR 5,967 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-1-US | new |
| 2024-03-31 | Expenditure | EUR 448 | Drugs for Neglected Diseases initiative | Expenses - 13-2403-2-US-XM-DAC-7 | new |
| 2024-04-30 | Expenditure | EUR 503 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-BR-DAC-1601 | new |
| 2024-04-30 | Expenditure | EUR 595 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-BR | new |
| 2024-04-30 | Expenditure | EUR 4,781 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-3-BR | new |
| 2024-04-30 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-4-BR-XM-DAC-7 | new |
| 2024-04-30 | Expenditure | EUR 1,742 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-5-BR-NO-BRC-971277882 | new |
| 2024-04-30 | Expenditure | EUR 307 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-6-BR | new |
| 2024-04-30 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-7-BR-CH-4 | new |
| 2024-04-30 | Expenditure | EUR 1,259 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-CG-DAC-1601 | new |
| 2024-04-30 | Expenditure | EUR 62k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-CG | new |
| 2024-04-30 | Expenditure | EUR 231k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-3-CG | new |
| 2024-04-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-4-CG-NO-BRC-971277882 | new |
| 2024-04-30 | Expenditure | EUR 8,341 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-5-CG | new |
| 2024-04-30 | Expenditure | EUR 733 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-CH | new |
| 2024-04-30 | Expenditure | EUR 223k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-CH-DAC-1601 | new |
| 2024-04-30 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-3-CH | new |
| 2024-04-30 | Expenditure | EUR 25k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-4-CH | new |
| 2024-04-30 | Expenditure | EUR 2,489 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-5-CH-XM-DAC-7 | new |
| 2024-04-30 | Expenditure | EUR 35k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-6-CH-NO-BRC-971277882 | new |
| 2024-04-30 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-7-CH | new |
| 2024-04-30 | Expenditure | EUR 8,800 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-8-CH | new |
| 2024-04-30 | Expenditure | EUR 81 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-KE-DAC-1601 | new |
| 2024-04-30 | Expenditure | EUR 2,241 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-KE | new |
| 2024-04-30 | Expenditure | EUR 19 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-3-KE | new |
| 2024-04-30 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 13-2404-4-KE-NO-BRC-971277882 | new |
| 2024-04-30 | Expenditure | EUR 5,867 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-5-KE | new |
| 2024-04-30 | Expenditure | EUR 306 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-MY | new |
| 2024-04-30 | Expenditure | EUR 918 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-MY | new |
| 2024-04-30 | Expenditure | EUR 742 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-3-MY-NO-BRC-971277882 | new |
| 2024-04-30 | Expenditure | EUR 2 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-1-US | new |
| 2024-04-30 | Expenditure | EUR 7,003 | Drugs for Neglected Diseases initiative | Expenses - 13-2404-2-US | new |
| 2024-05-31 | Expenditure | EUR 157 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-BR-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 2,148 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-BR | new |
| 2024-05-31 | Expenditure | EUR 4,618 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-3-BR | new |
| 2024-05-31 | Expenditure | EUR 1,745 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-4-BR-NO-BRC-971277882 | new |
| 2024-05-31 | Expenditure | EUR 298 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-5-BR | new |
| 2024-05-31 | Expenditure | EUR 207 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-CG | new |
| 2024-05-31 | Expenditure | EUR 5,024 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-CG-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 81k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-3-CG | new |
| 2024-05-31 | Expenditure | EUR 167k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-4-CG | new |
| 2024-05-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-5-CG-NO-BRC-971277882 | new |
| 2024-05-31 | Expenditure | EUR 1,806 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-CH | new |
| 2024-05-31 | Expenditure | EUR 118k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-CH-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-3-CH | new |
| 2024-05-31 | Expenditure | EUR 34k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-4-CH | new |
| 2018-03-31 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-CD-XM-DAC-7 | |
| 2018-03-31 | Expenditure | EUR 51k | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-CH-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 3,862 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-CH-XM-DAC-7 | |
| 2018-03-31 | Expenditure | EUR 17k | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-FR-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 5,299 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-GB-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 3,570 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-IT | |
| 2018-03-31 | Expenditure | EUR 5,253 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-SN-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 2,350 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-US-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 4,441 | CH-FDJP-CHE110141200 | Expenses - 13-1803-2-ZA-GB-GOV-1 | |
| 2018-03-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 13-1803-3-CH-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 125k | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-BE-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 134k | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-CD-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 1,685 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-CD-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 2,698 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-CH | |
| 2018-04-30 | Expenditure | EUR 43k | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-CH-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 956 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-FR | |
| 2018-04-30 | Expenditure | EUR 31k | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-FR-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-GB-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 1,984 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-GN-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 2,274 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-KR-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 3,817 | CH-FDJP-CHE110141200 | Expenses - 13-1804-1-US-DAC-1601 | |
| 2018-04-30 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-CD | |
| 2018-04-30 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-CD-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 206 | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-CH | |
| 2018-04-30 | Expenditure | EUR 12k | CH-FDJP-CHE110141200 | Expenses - 13-1804-3-CD-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 51k | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-CH-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 3,769 | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-CH-XM-DAC-7 | |
| 2018-04-30 | Expenditure | EUR 975 | CH-FDJP-CHE110141200 | Expenses - 13-1804-2-KR-GB-GOV-1 | |
| 2018-04-30 | Expenditure | EUR 9,116 | CH-FDJP-CHE110141200 | Expenses - 13-1804-3-CH-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-BE-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 120 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CD | |
| 2018-05-31 | Expenditure | EUR 230k | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CD-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 248 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CD-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 135 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CH | |
| 2018-05-31 | Expenditure | EUR 220k | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CH-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 1,628 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-CH-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 5,085 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-DE-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 2,411 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-FR | |
| 2018-05-31 | Expenditure | EUR 26k | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-FR-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-GB-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 3,996 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-GN-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 3,425 | CH-FDJP-CHE110141200 | Expenses - 13-1805-1-US-DAC-1601 | |
| 2018-05-31 | Expenditure | EUR 43k | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-CD | |
| 2018-05-31 | Expenditure | EUR 7,500 | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-CD-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 485 | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-CH | |
| 2018-05-31 | Expenditure | EUR 47k | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-CH-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 3,678 | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-CH-XM-DAC-7 | |
| 2018-05-31 | Expenditure | EUR 3,585 | CH-FDJP-CHE110141200 | Expenses - 13-1805-2-FR | |
| 2018-05-31 | Expenditure | EUR 17 | CH-FDJP-CHE110141200 | Expenses - 13-1805-3-CD | |
| 2018-05-31 | Expenditure | EUR 4,462 | CH-FDJP-CHE110141200 | Expenses - 13-1805-3-CD-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 50 | CH-FDJP-CHE110141200 | Expenses - 13-1805-3-CH | |
| 2018-05-31 | Expenditure | EUR 8,298 | CH-FDJP-CHE110141200 | Expenses - 13-1805-3-CH-GB-GOV-1 | |
| 2018-05-31 | Expenditure | EUR 214 | CH-FDJP-CHE110141200 | Expenses - 13-1805-3-FR | |
| 2018-05-31 | Expenditure | EUR 13k | CH-FDJP-CHE110141200 | Expenses - 13-1805-4-CD-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 193k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-CD-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 407 | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-CH | |
| 2018-06-30 | Expenditure | EUR 252k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-CH-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 1,550 | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-CL-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 1,347 | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-FR | |
| 2018-06-30 | Expenditure | EUR 156k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-FR-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 20k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-GB-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 459 | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-GN | |
| 2018-06-30 | Expenditure | EUR 11k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-IT-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 227 | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-JO | |
| 2018-06-30 | Expenditure | EUR 31k | CH-FDJP-CHE110141200 | Expenses - 13-1806-1-US-DAC-1601 | |
| 2018-06-30 | Expenditure | EUR 6,821 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-CD | |
| 2018-06-30 | Expenditure | EUR 7,579 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-CD-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 832 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-CH | |
| 2018-06-30 | Expenditure | EUR 6,794 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-CH-XM-DAC-7 | |
| 2018-06-30 | Expenditure | EUR 330 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-GB | |
| 2018-06-30 | Expenditure | EUR 1,071 | CH-FDJP-CHE110141200 | Expenses - 13-1806-2-GN | |
| 2018-06-30 | Expenditure | EUR 10k | CH-FDJP-CHE110141200 | Expenses - 13-1806-3-CD-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 3,711 | CH-FDJP-CHE110141200 | Expenses - 13-1806-3-CH-GB-GOV-1 | |
| 2018-06-30 | Expenditure | EUR 403 | CH-FDJP-CHE110141200 | Expenses - 13-1806-3-GB | |
| 2018-07-31 | Expenditure | EUR 308k | CH-FDJP-CHE110141200 | Expenses - 13-1807-1-CD-DAC-1601 | |
| 2018-07-31 | Expenditure | EUR 1,754 | CH-FDJP-CHE110141200 | Expenses - 13-1807-1-CH | |
| 2018-07-31 | Expenditure | EUR 89k | CH-FDJP-CHE110141200 | Expenses - 13-1807-1-CH-DAC-1601 | |
| 2018-07-31 | Expenditure | EUR 93 | CH-FDJP-CHE110141200 | Expenses - 13-1807-1-CN-DAC-1601 | |
| 2018-07-31 | Expenditure | EUR 36k | CH-FDJP-CHE110141200 | Expenses - 13-1807-1-FR | |
| 2024-05-31 | Expenditure | EUR 753 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-5-CH-XM-DAC-7 | new |
| 2024-05-31 | Expenditure | EUR 43k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-6-CH-NO-BRC-971277882 | new |
| 2024-05-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-7-CH | new |
| 2024-05-31 | Expenditure | EUR 4,960 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-8-CH | new |
| 2024-05-31 | Expenditure | EUR 396 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-KE | new |
| 2024-05-31 | Expenditure | EUR 63 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-KE-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 1,493 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-3-KE | new |
| 2024-05-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 13-2405-4-KE-NO-BRC-971277882 | new |
| 2024-05-31 | Expenditure | EUR 1,437 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-5-KE | new |
| 2024-05-31 | Expenditure | EUR 14 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-MY-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 16 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-MY | new |
| 2024-05-31 | Expenditure | EUR 893 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-3-MY | new |
| 2024-05-31 | Expenditure | EUR 932 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-4-MY-NO-BRC-971277882 | new |
| 2024-05-31 | Expenditure | EUR 7,065 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-1-US-DAC-1601 | new |
| 2024-05-31 | Expenditure | EUR 29 | Drugs for Neglected Diseases initiative | Expenses - 13-2405-2-US | new |
| 2024-06-30 | Expenditure | EUR 4,678 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-BR-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 258 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-BR | new |
| 2024-06-30 | Expenditure | EUR 1,334 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-3-BR | new |
| 2024-06-30 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-4-BR-XM-DAC-7 | new |
| 2024-06-30 | Expenditure | EUR 1,952 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-5-BR-NO-BRC-971277882 | new |
| 2024-06-30 | Expenditure | EUR 5,216 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-CG | new |
| 2024-06-30 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-CG-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 104k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-3-CG | new |
| 2024-06-30 | Expenditure | EUR 37k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-4-CG | new |
| 2024-06-30 | Expenditure | EUR 5,296 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-5-CG-XM-DAC-7 | new |
| 2024-06-30 | Expenditure | EUR 30k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-6-CG-NO-BRC-971277882 | new |
| 2024-06-30 | Expenditure | EUR 8,776 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-7-CG | new |
| 2024-06-30 | Expenditure | EUR 3,363 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-CH | new |
| 2024-06-30 | Expenditure | EUR 320k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-CH-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-3-CH | new |
| 2024-06-30 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-4-CH | new |
| 2024-06-30 | Expenditure | EUR 748 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-5-CH-XM-DAC-7 | new |
| 2024-06-30 | Expenditure | EUR 36k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-6-CH-NO-BRC-971277882 | new |
| 2024-06-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-7-CH | new |
| 2024-06-30 | Expenditure | EUR 4,861 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-8-CH | new |
| 2024-06-30 | Expenditure | EUR 412 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-KE | new |
| 2024-06-30 | Expenditure | EUR 63 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-KE-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 581 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-3-KE | new |
| 2024-06-30 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-4-KE-NO-BRC-971277882 | new |
| 2024-06-30 | Expenditure | EUR 1,263 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-5-KE | new |
| 2024-06-30 | Expenditure | EUR 697 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-MY-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 73 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-MY | new |
| 2024-06-30 | Expenditure | EUR 1,011 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-3-MY-NO-BRC-971277882 | new |
| 2024-06-30 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 13-2406-1-US-DAC-1601 | new |
| 2024-06-30 | Expenditure | EUR 1,316 | Drugs for Neglected Diseases initiative | Expenses - 13-2406-2-US | new |
Showing 300 of 2,638. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.